Category: Pharmaceuticals
The acquisition is expected to be highly earnings enhancing for the commercial medicines division as well as the whole group. Clinigen Group, the multinational pharmaceutical and services company, has …
The drug has specifically been developed for treating acquired Thrombotic Thrombocytopenic Purpura in adult patients. Cablivi’s efficacy was studied in a clinical trial which saw participation from over 145 …
Swisshealthcare company Roche will reportedly be donating its new hemophilia A drugHemlibra for a World Hemophilia Federation program, the company said.Apparently, Roche will be joining its rivals who also …
Roche, a Swiss multinational healthcare company, has reportedly announced its plans to broaden breast cancer treatment with the newer breast cancer drug Kadcyla. The move comes in the wake …
The CHMP (Committee for Medicinal Products for Human Use), owned by the European Medicines Agency (EMA), has recommended approval for Praluent (alirocumab), a drug developed by Sanofi and the …
The investment will help support Solara Active’s expansion in its regulated markets and is expected to close in early 2019, subject to regulatory and shareholder approval. Renowned private equity …
In close collaboration with WARF, Invenra’s SNIPER™ technology is expected to help create antibody-based therapies to advance pediatric neuroblastoma treatment Invenra, a Wisconsin-based biotechnology company, has reportedly entered into …
The Breakthrough Therapy Designation program is specifically designed to accelerate the development & review for medications designed for life-threatening conditions. The vaccine received the designation for facilitating the prevention …
Dewpoint Therapeutics, a biopharma company that translates the evolving area of biomolecular condensates into drug discovery, has recently announced its debut with USD 60 million in a series A …
The new drug has been found to be an effective analgesic without being addictive. Pfizer Inc., the leading American pharmaceutical corporation, and the global healthcare conglomerate, Eli Lilly & …
